Company
CNSX: CHGX
ChitogenX Inc. (formally Ortho Regenerative Technologies Inc.) is a publicly traded (CSE: CHGX, OTCQB: CHNXF) clinical stage regenerative medicine company dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing. The Company name change better reflects the breadth of potential clinical and commercial applications for our proprietary chitosan-based biopolymer and biologic combination.
21 stories · page 2 of 2
"The meniscus preclinical study will be our second proof of concept for our proprietary ORTHO-R drug/biologic product in an orthopedic indication with high unmet medical needs," said company CEO Philippe Deschamps
